Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for JNJ
118.13
+0.86 (0.73%)
Sep 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 117.39 - 118.62
52 week 91.76 - 126.07
Open 117.78
Vol / Avg. 7.94M/6.14M
Mkt cap 317.45B
P/E 22.01
Div/yield 0.80/2.71
EPS 5.37
Shares 2.74B
Beta 0.61
Inst. own 67%
Oct 18, 2016
Q3 2016 Johnson & Johnson Earnings Release - 9:30AM EDT - Add to calendar
Oct 18, 2016
Q3 2016 Johnson & Johnson Earnings Call - 8:30AM EDT - Add to calendar
Sep 14, 2016
Johnson & Johnson at Morgan Stanley Global Healthcare Conference
Sep 8, 2016
Johnson & Johnson at Wells Fargo Securities Healthcare Conference
Jul 19, 2016
Q2 2016 Johnson & Johnson Earnings Release
Jul 19, 2016
Q2 2016 Johnson & Johnson Earnings Call - Webcast
Jul 5, 2016
Johnson & Johnson DARZALEX´┐Ż (daratumumab) Phase 3 Data and Janssen Immuno-oncology Strategy Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '16) 2016
Net profit margin 21.63% 21.99%
Operating margin 29.74% 24.50%
EBITD margin - 32.62%
Return on average assets 11.62% 11.65%
Return on average equity 22.09% 21.87%
Employees 127,100 -
CDP Score - 99 B

Address

1 Johnson And Johnson Plz
NEW BRUNSWICK, NJ 08933-0001
United States - Map
+1-732-5242455 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company's segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on over five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Officers and directors

Alex Gorsky Chairman of the Board, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Dominic J. Caruso Chief Financial Officer, Vice President - Finance
Age: 58
Bio & Compensation  - Reuters
Sandra E. Peterson Group Worldwide Chairman
Age: 57
Bio & Compensation  - Reuters
Paulus A. Stoffels Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group
Age: 54
Bio & Compensation  - Reuters
Michael H. Ullmann Vice President, General Counsel
Age: 57
Bio & Compensation  - Reuters
Peter M. Fasolo Ph.D. Vice President - Global Human Resources
Age: 53
Bio & Compensation  - Reuters
Louise Mehrotra Vice President, Investor Relations
Bio & Compensation  - Reuters
Joseph Wolk Vice President - Investor Relations
Bio & Compensation  - Reuters
Anne M. Mulcahy Lead Independent Director
Age: 63
Bio & Compensation  - Reuters
Mary C. Beckerle Ph.D. Director
Age: 61
Bio & Compensation  - Reuters